 Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores
Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore
Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore
LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects
NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects Lemon Tree Hotels signs 11th property in Punjab
Lemon Tree Hotels signs 11th property in Punjab 
              Eris Lifesciences Ltd has approved the allotment of 2161 equity shares of Re. 1/- each at a premium of Rs. 450.04/- per share has been made on 20.11.2018, pursuant to exercise of options under its ESOP-2017 Scheme.
The paid up share capital of the Company has accordingly been increased from Rs. 13,75,15,461/- (13,75,15,461 equity shares of Re. 1/- each) to Rs. 13,75,17,622/- (13,75,17,622 equity shares of Re. 1/- each).
Shares of Eris Lifesciences Ltd was last trading in BSE at Rs.612.35 as compared to the previous close of Rs. 612.5. The total number of shares traded during the day was 353 in over 33 trades.
The stock hit an intraday high of Rs. 617.45 and intraday low of 610. The net turnover during the day was Rs. 216769.